NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.20091.a: 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (MG_430)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: diffraction
center reference id: MygeA.20091.a
is community request: True
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MygeA.20091.a.B1.GE42354 Full length(MygeA.20091.a) 1 507 GE42354
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MygeA.20091.a.B1.PW38481 Full length(MygeA.20091.a) 1 507

Molecular models

Method Results
comparative modelling Robetta_81212

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.496
UniProt: P47669

Enzyme & Pathway Information

Pathway Pathway ID EC Number
homolactic fermentation ANAEROFRUCAT-PWY 5.4.2.12
glycolysis III (from glucose) ANAGLYCOLYSIS-PWY 5.4.2.12
gluconeogenesis I GLUCONEO-PWY 5.4.2.12
glycolysis I (from glucose 6-phosphate) GLYCOLYSIS 5.4.2.12
superpathway of glycolysis and the Entner-Doudoroff pathway GLYCOLYSIS-E-D 5.4.2.12
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass GLYCOLYSIS-TCA-GLYOX-BYPASS 5.4.2.12
superpathway of hexitol degradation (bacteria) HEXITOLDEGSUPER-PWY 5.4.2.12
Bifidobacterium shunt P124-PWY 5.4.2.12
glycolysis V (Pyrococcus) P341-PWY 5.4.2.12
superpathway of N-acetylneuraminate degradation P441-PWY 5.4.2.12
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 5.4.2.12
glycolysis IV (plant cytosol) PWY-1042 5.4.2.12
Entner-Doudoroff pathway III (semi-phosphorylative) PWY-2221 5.4.2.12
superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle PWY-5464 5.4.2.12
glycolysis II (from fructose 6-phosphate) PWY-5484 5.4.2.12
Rubisco shunt PWY-5723 5.4.2.12
gluconeogenesis II (Methanobacterium thermoautotrophicum) PWY-6142 5.4.2.12
Methanobacterium thermoautotrophicum biosynthetic metabolism PWY-6146 5.4.2.12
1-butanol autotrophic biosynthesis (engineered) PWY-6886 5.4.2.12
superpathway of glucose and xylose degradation PWY-6901 5.4.2.12
glycerol degradation to butanol PWY-7003 5.4.2.12
ethylene biosynthesis V (engineered) PWY-7124 5.4.2.12
photosynthetic 3-hydroxybutanoate biosynthesis (engineered) PWY-7218 5.4.2.12
superpathway of anaerobic sucrose degradation PWY-7345 5.4.2.12

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MHKKVLLAIL DGYGISNAIY GNAVQNANTP MLDELINSYP CVLLDASGEA VGLPMGQIGN SEVGHLNIGA GRVVYTGLSL INQHIKDRSF FANKAFLKTI EHVEKNHSKI HLIGLFSNGG VHSHNEHLLA LIELFSKHAK VVLHLFGDGR DVAPCSLKQD LEKLMIFLKN YPNVVIGTIG GRYYGMDRDQ RWDREMIAYK ALLGVSKNKF NDPIGYIETQ YQNQITDEFI YPAINANLNS DQFALNNNDG VISFNFRPDR ARQMSHLIFN SNYYNYQPEL KRKENLFFVT MMNYEGIVPS EFAFPPQTIK NSLGEVIANN NLKQLRIAET EKYAHVTFFF DGGFEVNLSN ETKTLIPSLK VATYDLAPEM SCKAITDALL EKLNNFDFTV LNFANPDMVG HTGNYQACIK ALEALDVQIK RIVDFCKANQ ITMFLTADHG NAEVMIDNNN NPVTKHTINP VPFVCTDKNV NFNQTGILAN IAPTILEYLN LSKPKEMTAK SLLKNNN

NT Sequence
ATGCATAAAA AAGTTTTATT AGCAATCCTT GATGGTTATG GGATCTCAAA TGCTATTTAT GGTAATGCAG TACAAAATGC AAATACCCCA ATGCTAGATG AATTAATCAA TTCATATCCT TGTGTACTTT TAGATGCATC TGGGGAAGCA GTTGGATTGC CTATGGGTCA AATAGGTAAC TCTGAGGTAG GTCATCTAAA TATTGGGGCA GGTCGAGTTG TTTATACTGG ACTTTCTTTG ATTAATCAAC ATATTAAGGA TCGTAGTTTT TTTGCAAATA AAGCTTTTTT AAAAACCATA GAACATGTAG AAAAAAACCA TTCAAAAATC CATTTAATTG GGTTATTTTC CAATGGAGGA GTGCATAGTC ATAATGAACA TCTATTAGCA CTCATTGAAT TGTTTTCAAA ACATGCAAAG GTAGTATTAC ATTTATTTGG TGATGGTAGA GATGTAGCAC CTTGTAGCTT AAAACAAGAT CTTGAGAAAT TAATGATATT TCTAAAAAAC TATCCTAATG TTGTTATTGG AACTATTGGG GGAAGATACT ATGGAATGGA TCGTGATCAA CGCTGGGATC GTGAAATGAT TGCTTATAAA GCTTTATTAG GAGTTTCAAA AAATAAATTC AATGACCCAA TTGGTTATAT TGAAACGCAA TATCAGAACC AAATTACTGA TGAATTTATT TATCCTGCAA TTAATGCCAA TTTAAATTCT GATCAGTTTG CATTAAACAA TAATGATGGA GTTATTTTCT TTAATTTTAG ACCTGATAGA GCAAGACAAA TGTCCCATTT GATCTTTAAC AGCAATTATT ACAACTATCA ACCTGAATTG AAACGAAAAG AAAATTTATT TTTTGTAACA ATGATGAATT ATGAGGGAAT TGTACCTAGC GAATTTGCTT TTCCACCTCA AACCATTAAA AATAGTCTTG GTGAAGTAAT TGCTAATAAT AATTTGAAGC AATTGAGGAT TGCAGAAACT GAAAAGTATG CTCACGTTAC TTTCTTTTTT GATGGTGGTT TTGAAGTTAA TCTCAGCAAT GAAACAAAGA CATTAATTCC TTCTTTAAAA GTTGCTACAT ATGATTTAGC TCCCGAAATG TCATGTAAAG CTATTACTGA TGCACTACTA GAAAAGCTTA ATAACTTTGA TTTTACTGTT TTAAATTTTG CTAATCCTGA TATGGTAGGT CATACTGGTA ACTATCAAGC TTGCATTAAA GCTCTTGAAG CACTCGATGT TCAAATTAAA CGAATAGTTG ATTTTTGTAA AGCTAATCAA ATAACTATGT TTTTAACTGC AGATCATGGG AATGCAGAAG TGATGATTGA TAATAATAAC AATCCAGTTA CTAAACACAC TATTAATCCT GTACCATTTG TATGTACTGA CAAAAATGTT AACTTTAATC AAACTGGAAT TTTAGCTAAT ATTGCTCCTA CTATCTTGGA ATATCTTAAC CTTAGCAAAC CAAAAGAGAT GACTGCAAAA TCCTTATTAA AAAATAACAA T

© 2020 Seattle Children's Research Institute. All rights reserved.